US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics Inc (PLRX) ニュース

PLRX

Pliant Therapeutics (PLRX)

Pliant Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PLRX

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	20 : 43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/14	20 : 30	GlobeNewswire Inc.	Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/07	21 : 00	GlobeNewswire Inc.	Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/07	05 : 27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/07	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/07	05 : 05	GlobeNewswire Inc.	Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/06	19 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/05/01	21 : 00	GlobeNewswire Inc.	Pliant Therapeutics to Participate in Upcoming Investor Events	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/04/02	21 : 00	GlobeNewswire Inc.	Pliant Therapeutics to Participate in Upcoming Investor Events	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/03/27	23 : 23	GlobeNewswire Inc.	Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/03/12	20 : 30	GlobeNewswire Inc.	Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/28	06 : 20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/28	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/28	06 : 03	GlobeNewswire Inc.	Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	Pliant Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/15	10 : 55	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/14	22 : 52	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/07	22 : 00	GlobeNewswire Inc.	Pliant Therapeutics to Participate in Upcoming Investor Events	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/05	21 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/02/05	05 : 29	GlobeNewswire Inc.	Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/25	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/25	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/25	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/25	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/20	07 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/20	07 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/20	07 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLRX	Pliant Therapeutics Inc
2024/01/03	22 : 00	GlobeNewswire Inc.	Pliant Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:PLRX	Pliant Therapeutics Inc
2023/11/14	06 : 30	GlobeNewswire Inc.	Pliant Therapeutics Presentations at The Liver Meeting® 2023 Highlight Bexotegrast, an Inhibitor of αvß6 and αvß1 Integrins, in Primary Sclerosing Cholangitis	NASDAQ:PLRX	Pliant Therapeutics Inc
2023/11/10	06 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLRX	Pliant Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:PLRX

1 2 3 4 5 6 7 8 9 次へ >>

Javelin Minerals

Atlas Financial (PK)

Societe Generale Effekten

Voestalpine (PK)

ProMIS Neurosciences

Interpace Biosciences (QX)

CoinShares Physical Bitc...

Cigarette Token

Avecho Biotechnology

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約